NCT05763693View on ClinicalTrials.gov

Vitality in Infants Via Azithromycin for Neonates Trial

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

4,000

Participants

Timeline

Start Date

April 30, 2026

Primary Completion Date

April 30, 2030

Study Completion Date

April 30, 2030

Conditions
Neonatal DeathInfectious DiseaseNutritional Deficiency
Interventions
DRUG

Azithromycin at Baseline

this group will be randomized to receive a single oral dose of azithromycin (20mg/kg) at baseline

DRUG

Azithromycin at Day 21

this group will be randomized to receive a single oral dose of azithromycin (20mg/kg) at the day 21 visit

OTHER

Placebo at Baseline

this group will be randomized to receive Placebo at baseline

OTHER

Placebo at Day 21

This group will be randomized to receive Placebo at the day 21 visit

Trial Locations (1)

BP02

Centre de Recherche en santé de Nouna, Nouna

All Listed Sponsors
collaborator

Centre de Recherche en Sante de Nouna, Burkina Faso

OTHER_GOV

lead

University of California, San Francisco

OTHER